1. Home
  2. RIP
  3. View Record
https://www.nationalacademies.org/trb/events

Neurocognitive Validation & Transition Study – Phase 1, Rev B

The Office of Aerospace Medicine is evaluating alternative neurocognitive screening tools to support pilot medical certification and reduce reliance on the Federal Aviation Administration's (FAA’s) current single-vendor, proprietary test, which presents continuity and operational risk if the product becomes unavailable or compromised. The FAA has partnered with multiple developers to produce derivative tests tailored for aviation use; however, an independent expert assessment is required to determine whether these tools are ready for operational deployment or require additional validation. This research will provide that assessment, ensuring that neurocognitive impairment relevant to pilot performance can be reliably identified before it presents safety risk, and will directly inform whether the derivative tools can be adopted as-is or whether further reliability, feasibility, or validation studies are needed to support future implementation decisions.